source
- BD and CareFusion recall Alaris Pump infusion sets due to serious performance risksThe FDA has classified the recall of BD Alaris Pump infusion sets as the most serious type, warning that continued use could cause serious injury or death. BD and its subsidiary CareFusion sent an…
- MIT reports 20% drop in graduate enrollment after $100 million federal research cut, warning of basic-research droughtMIT President Sally Kornbluth told the STAT Summit that the university saw a 20% decline in new graduate students this fall, linked to a $100 million reduction in federal research awards over the p…STAT · 6d agoRegulatoryNegative